Bloomberg: Arthur Hayes has recently made a significant investment in a human longevity company, regularly receiving stem cell intravenous infusion therapy over the past year.

On August 21, Bloomberg reported that CEX co-founder Arthur Hayes is shifting his investment focus toward the field of human lifespan extension. He has recently made a significant investment in a stem cell company with clinics in Mexico and Bangkok and has joined its board of directors. Over the past year, he has regularly traveled to receive intravenous infusion therapy, stating that "I hope to extend my lifespan as healthily as possible." Although the company name has not been disclosed due to a rebranding, he emphasized: "This is the trend of the future — more and more countries are relaxing regulations on the use of stem cells."

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)